FDA Approves ‘Landmark’ Cancer Drug That Extended Patients’ Lives in Trial

The short version
- Ben Sasse of Nebraska has seen very positive results using it while it was still in its experimental phase.
- The drug, known as Rasonque, “a tablet taken once daily, targets multiple forms […] The post FDA Approves ‘Landmark’ Cancer Drug That Extended Patients’…
The story
The Food and Drug Administration announced Wednesday the approval of a new pancreatic cancer treatment drug that nearly doubles patients’ survival times. Former GOP Sen. Ben Sasse of Nebraska has seen very positive results using it while it was still in its experimental phase. The drug, known as Rasonque, “a tablet taken once daily, targets multiple forms […]
The post FDA Approves ‘Landmark’ Cancer Drug That Extended Patients’ Lives in Trial appeared first on Charisma Magazine Online.
How other outlets covered this
Compare allAlto found this story at 2 outlets. Same event, different framing — compare the headlines.
Powered by Gab AI
The Story At A Glance
Reading this article now — analysis appears below
💡 AI analysis provides alternative perspectives on current events